InsidersTradesSigma
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Goetz Kathleen, Director. Officer active across 4 companies, notably Tekla World Healthcare Fund. In total, 12 reports have been recorded. Total volume traded: €79k. The latest transaction was disclosed on 23 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€1,36069.188 shares@ €19.66050.0002% mcap6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037467:0·
Ideal exit: 18 Dec 2022 (T+270)
€1,36292.308 shares@ €14.7510.0003% mcap6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037465:0·
Ideal exit: 18 Dec 2022 (T+270)
€1,36173.529 shares@ €18.50980.0001% mcap6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037466:0·
Ideal exit: 18 Dec 2022 (T+270)
€1,361103.377 shares@ €13.16440.0003% mcap6.9% of flow
Shares of Beneficial Interest
SEC:0001104659-22-037468:0·
Ideal exit: 18 Dec 2022 (T+270)
€9,154481 shares@ €19.03220.0008% mcap46.5% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008200:0·
Ideal exit: 23 Oct 2022 (T+270)
€9,222714 shares@ €12.9167100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008203·
Ideal exit: 23 Oct 2022 (T+270)
€9,203593 shares@ €15.5195100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008199·
Ideal exit: 23 Oct 2022 (T+270)
€9,208479 shares@ €19.2224100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008201·
Ideal exit: 23 Oct 2022 (T+270)
€9,154481 shares@ €19.0322100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008200·
Ideal exit: 23 Oct 2022 (T+270)
€9,222714 shares@ €12.91670.0018% mcap46.6% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008203:0·
Ideal exit: 23 Oct 2022 (T+270)
€9,203593 shares@ €15.51950.0021% mcap46.6% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008199:0·
Ideal exit: 23 Oct 2022 (T+270)
€9,208479 shares@ €19.22240.0013% mcap46.6% of flow
Shares of Beneficial Interest
SEC:0001104659-22-008201:0·
Ideal exit: 23 Oct 2022 (T+270)
12 of 12 declarations
About Goetz Kathleen
Kathleen Goetz is a Board Member at Tekla World Healthcare Fund, Tekla Life Sciences Investors, and Tekla Healthcare Opportunities Fund. She brings her expertise to the board, contributing to the governance and strategic direction of these investment funds.
